TickerFactsScreenerDevelopers

FILANA THERAPEUTICS, INC. (FLNA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $153.16M2009: $35.79M2010: $4.80M2011: $73.14M2012: $49.35M2013: $48.59M2014: $40.59M2015: $31.30M2016: $16.61M2017: $10.48M2018: $19.81M2019: $23.08M2020: $93.51M2021: $233.44M2022: $201.01M2023: $121.14M2024: $128.57M2025: $95.50M$95.50M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$95.50M-25.7%
2024$128.57M+6.1%
2023$121.14M-39.7%
2022$201.01M-13.9%
2021$233.44M+149.6%
2020$93.51M+305.1%
2019$23.08M+16.5%
2018$19.81M+89.0%
2017$10.48M-36.9%
2016$16.61M-46.9%
2015$31.30M-22.9%
2014$40.59M-16.5%
2013$48.59M-1.6%
2012$49.35M-32.5%
2011$73.14M+1424.5%
2010$4.80M-86.6%
2009$35.79M-76.6%
2008$153.16M—